Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76951 - 76975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tanespimycin	Investigational	PNN	5411	upregulated	tanespimycin results in increased expression of PNN mRNA	14q21.1	A24391
Tanespimycin	Investigational	SERPINB5	5268	upregulated	tanespimycin results in increased expression of SERPINB5 mRNA	18q21.33	A24391
Tanespimycin	Investigational	TIMP3	7078	upregulated	tanespimycin results in increased expression of TIMP3 mRNA	22q12.3	A24391
Tapentadol	Approved Investigational	ALDOC	230	upregulated	tapentadol results in increased expression of ALDOC mRNA	17q11.2	A24392
Tapentadol	Approved Investigational	CKB	1152	downregulated	tapentadol results in decreased expression of CKB mRNA	14q32.33	A24392
Tapentadol	Approved Investigational	LDHA	3939	downregulated	tapentadol results in decreased expression of LDHA mRNA	11p15.1	A24392
Tapentadol	Approved Investigational	NDUFS1	4719	downregulated	tapentadol results in decreased expression of NDUFS1 mRNA	2q33.3	A24392
Tapentadol	Approved Investigational	PDK3	5165	upregulated	tapentadol results in increased expression of PDK3 mRNA	Xp22.11	A24392
Taurine	Approved Investigational Nutraceutical	ABL2	27	upregulated	Taurine results in increased expression of ABL2 mRNA	1q25.2	A24393
Taurine	Approved Investigational Nutraceutical	ADAP2	55803	upregulated	Taurine results in increased expression of ADAP2 mRNA	17q11.2	A24393
Taurine	Approved Investigational Nutraceutical	ADORA2A	135	downregulated	Taurine results in decreased expression of ADORA2A mRNA	22q11.23	A24393
Taurine	Approved Investigational Nutraceutical	ADRA1B	147	upregulated	Taurine results in increased expression of ADRA1B mRNA	5q33.3	A24393
Taurine	Approved Investigational Nutraceutical	BID	637	downregulated	Taurine results in decreased expression of BID mRNA	22q11.21	A24393
Taurine	Approved Investigational Nutraceutical	BMPR2	659	downregulated	Taurine results in decreased expression of BMPR2 mRNA	2q33.1-q33.2	A24393
Taurine	Approved Investigational Nutraceutical	CAP2	10486	downregulated	Taurine results in decreased expression of CAP2 mRNA	6p22.3	A24393
Taurine	Approved Investigational Nutraceutical	CAP2	10486	upregulated	Taurine results in increased expression of CAP2 mRNA	6p22.3	A24393
Taurine	Approved Investigational Nutraceutical	CGA	1081	upregulated	Taurine results in increased expression of CGA mRNA	6q14.3	A24393
Taurine	Approved Investigational Nutraceutical	CHN1	1123	downregulated	Taurine results in decreased expression of CHN1 mRNA	2q31.1	A24393
Taurine	Approved Investigational Nutraceutical	COPS2	9318	upregulated	Taurine results in increased expression of COPS2 mRNA	15q21.2	A24393
Taurine	Approved Investigational Nutraceutical	CXCR3	2833	downregulated	Taurine results in decreased expression of CXCR3 mRNA	Xq13.1	A24393
Taurine	Approved Investigational Nutraceutical	DDAH1	23576	downregulated	Taurine results in decreased expression of DDAH1 mRNA	1p22.3	A24393
Taurine	Approved Investigational Nutraceutical	DGKZ	8525	upregulated	Taurine results in increased expression of DGKZ mRNA	11p11.2	A24393
Taurine	Approved Investigational Nutraceutical	EI24	9538	upregulated	Taurine results in increased expression of EI24 mRNA	11q24.2	A24393
Taurine	Approved Investigational Nutraceutical	FGFR1	2260	downregulated	Taurine results in decreased expression of FGFR1 mRNA	8p11.23	A24393
Taurine	Approved Investigational Nutraceutical	GRM7	2917	downregulated	Taurine results in decreased expression of GRM7 mRNA	3p26.1	A24393

Displaying entries 76951 - 76975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability